1.
Cancer incidence in Nigeria: A report from population-based cancer registries
by Jedy-Agba, Elima
Cancer epidemiology, 2012, Vol.36 (5), p.e271-e278
2.
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
by His, Mathilde
European journal of epidemiology, 2014-01-01, Vol.29 (2), p.119-132
3.
Impact of Socioeconomic Status on Cancer Incidence and Stage at Diagnosis: Selected Findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality S...
by Clegg, Limin X
Cancer causes & control, 2009-05-01, Vol.20 (4), p.417-435
4.
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
by Mars, Nina
Nature medicine, 2020-04, Vol.26 (4), p.549-557
5.
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
by Kerr, Jacqueline
The lancet oncology, 2017-08, Vol.18 (8), p.e457-e471
6.
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
by Gore, A. C
Endocrine reviews, 2015-12, Vol.36 (6), p.E1-E150
7.
Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges
by Mondul, Alison M
Epidemiologic reviews, 2017-01-01, Vol.39 (1), p.28-48
8.
Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
by Gore, A. C
Endocrine reviews, 2015-12, Vol.36 (6), p.593-602
9.
Rye bread consumption in early life and reduced risk of advanced prostate cancer
by Torfadottir, Johanna E
Cancer causes & control, 2012-06-01, Vol.23 (6), p.941-950
10.
Thyroid Function and Cancer Risk: The Rotterdam Study
by Khan, Samer R
The journal of clinical endocrinology and metabolism, 2016-12, Vol.101 (12), p.5030-5036
11.
Association between Metabolic Syndrome and Cancer
by Uzunlulu, Mehmet
Annals of nutrition and metabolism, 2016-01-01, Vol.68 (3), p.173-179
12.
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
by Sipahi, Ilke, Dr
The lancet oncology, 2010, Vol.11 (7), p.627-636
13.
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study
by Nam, Robert K, Prof
The lancet oncology, 2014, Vol.15 (2), p.223-231
14.
Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries
by Pukkala, Eero
Occupational and environmental medicine (London, England), 2014-06, Vol.71 (6), p.398-404
15.
Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report
by Stevens, Richard G
Occupational and Environmental Medicine, 2011-02, Vol.68 (2), p.154-162
16.
Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
by Jonasson, J. M
Diabetologia, 2009-07-09, Vol.52 (9), p.1745-1754
17.
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study
by Klemann, Nina, Dr
The lancet oncology, 2017, Vol.18 (2), p.221-229
18.
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
by Johnson, J. A
Diabetologia, 2011-07-12, Vol.54 (9), p.2263-2271
19.
Cancer patterns, trends, and transitions in Peru: a regional perspective
by Piñeros, Marion
The lancet oncology, 2017-10, Vol.18 (10), p.e573-e586
20.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-...
by Fransson, Per
The lancet oncology, 2021-02, Vol.22 (2), p.235-245
